LC
CME icon

Lindbrook Capital’s CME Group CME Stock Holding History

Lindbrook Capital’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$5.71M Sell
21,537
-4,359
-17% -$1.08M 0.53% 28
2024
Q4 		$6.01M Buy
25,896
+135
+0.5% +$31K 0.54% 30
2024
Q3 		$5.68M Buy
25,761
+5,109
+25% +$1.06M 0.5% 33
2024
Q2 		$4.06M Buy
20,652
+412
+2% +$85.1K 0.38% 44
2024
Q1 		$4.36M Sell
20,240
-934
-4% -$196K 0.41% 44
2023
Q4 		$4.46M Buy
21,174
+172
+0.8% +$36.7K 0.45% 43
2023
Q3 		$4.21M Buy
21,002
+269
+1% +$53.5K 0.47% 39
2023
Q2 		$3.84M Sell
20,733
-97
-0.5% -$17.9K 0.41% 45
2023
Q1 		$3.99M Sell
20,830
-4,206
-17% -$761K 0.47% 42
2022
Q4 		$4.21M Buy
25,036
+4,430
+21% +$770K 0.52% 35
2022
Q3 		$3.65M Buy
20,606
+11,093
+117% +$2.19M 0.62% 19
2022
Q2 		$1.95M Sell
9,513
-3,269
-26% -$693K 0.32% 36
2022
Q1 		$3.04M Buy
12,782
+67
+0.5% +$15.7K 0.47% 29
2021
Q4 		$2.9M Buy
12,715
+483
+4% +$106K 0.44% 29
2021
Q3 		$2.37M Sell
12,232
-835
-6% -$169K 0.62% 17
2021
Q2 		$2.78M Buy
13,067
+18
+0.1% +$3.8K 0.62% 21
2021
Q1 		$2.67M Buy
13,049
+50
+0.4% +$9.85K 0.6% 23
2020
Q4 		$2.37M Sell
12,999
-21
-0.2% -$3.57K 0.58% 23
2020
Q3 		$2.18M Buy
13,020
+44
+0.3% +$7.41K 0.6% 22
2020
Q2 		$2.11M Sell
12,976
-14,285
-52% -$2.56M 0.63% 20
2020
Q1 		$4.73M Sell
27,261
-123
-0.4% -$24.5K 1.79% 13
2019
Q4 		$5.5M Buy
27,384
+791
+3% +$162K 1.91% 7
2019
Q3 		$5.66M Buy
26,593
+28
+0.1% +$5.85K 2.14% 7
2019
Q2 		$5.16M Buy
26,565
+13,407
+102% +$2.47M 1.99% 8
2019
Q1 		$2.17M Sell
13,158
-188
-1% -$33.2K 0.86% 14
2018
Q4 		$2.51M Buy
+13,346
New +$2.46M 1.24% 8

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lindbrook Capital's CME Position: Q1 2025 in Review

Lindbrook Capital reduced its CME Group (CME) stake by 17% in Q1 2025, selling an estimated $1.08M and leaving 21,537 shares worth $5.71M. The position accounts for 0.53% of the portfolio, ranked #28.

Lindbrook Capital first reported a position in CME in Q4 2018 and has held it in 26 quarters since. The position peaked at $6.01M in Q4 2024. 1,597 funds tracked by Wall St. Rank hold CME as of Q1 2025.

  • Lindbrook Capital held 21,537 shares of CME Group worth $5.71M as of Q1 2025.
  • Lindbrook Capital sold 4,359 CME Group shares in Q1 2025, an estimated $1.08M.
  • CME Group made up 0.53% of Lindbrook Capital's portfolio in Q1 2025, its #28 holding.
  • Lindbrook Capital first reported a position in CME Group in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's CME Group position peaked at $6.01M in Q4 2024.
  • 1,597 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.